Search Results

There are 3522 results for: content related to: HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy

  1. You have full text access to this OnlineOpen article
    Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life

    HIV Medicine

    A Bamford, A Turkova, H Lyall, C Foster, N Klein, D Bastiaans, D Burger, S Bernadi, K Butler, E Chiappini, P Clayden, M Della Negra, V Giacomet, C Giaquinto, D Gibb, L Galli, M Hainaut, M Koros, L Marques, E Nastouli, T Niehues, A Noguera-Julian, P Rojo, C Rudin, HJ Scherpbier, G Tudor-Williams, SB Welch and (PENTA Steering Committee)

    Version of Record online : 3 FEB 2015, DOI: 10.1111/hiv.12217

  2. You have free access to this content
    Impact of reverse transcriptase resistance on the efficacy of TMC125 (etravirine) with two nucleoside reverse transcriptase inhibitors in protease inhibitor-naïve, nonnucleoside reverse transcriptase inhibitor-experienced patients: study TMC125-C227

    HIV Medicine

    Volume 9, Issue 10, November 2008, Pages: 883–896, K Ruxrungtham, RJ Pedro, GH Latiff, F Conradie, P Domingo, S Lupo, W Pumpradit, JH Vingerhoets, M Peeters, I Peeters, TN Kakuda, G De Smedt, B Woodfall and on behalf of the TMC125-C227 study group

    Version of Record online : 14 SEP 2008, DOI: 10.1111/j.1468-1293.2008.00644.x

  3. HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design

    Medicinal Research Reviews

    Volume 33, Issue S1, June 2013, Pages: E1–E72, Peng Zhan, Xuwang Chen, Dongyue Li, Zengjun Fang, Erik De Clercq and Xinyong Liu

    Version of Record online : 26 APR 2011, DOI: 10.1002/med.20241

  4. You have free access to this content
    Triple nucleoside reverse transcriptase inhibitor- vs. nonnucleoside reverse transcriptase inhibitor-containing regimens as first-line therapy: efficacy and durability in a prospective cohort of French HIV-infected patients

    HIV Medicine

    Volume 6, Issue 6, November 2005, Pages: 388–395, L Cuzin, P Pugliese, F Bugnon, C Delpierre, E Cua, E Billaud, P Massip, F Raffi and P Dellamonica

    Version of Record online : 28 OCT 2005, DOI: 10.1111/j.1468-1293.2005.00315.x

  5. You have free access to this content
    Combination antiretroviral therapy without a nucleoside reverse transcriptase inhibitor: experience from 334 patients in three cohorts

    HIV Medicine

    Volume 8, Issue 3, April 2007, Pages: 171–180, A Calmy, K Petoumenos, C Lewden, M Law, F Bocquentin, K Hesse, D Cooper, A Carr, F Bonnet and for the Aquitaine Cohort, Australian HIV Observational Database and St Vincent's Hospital Cohort study groups

    Version of Record online : 24 APR 2007, DOI: 10.1111/j.1468-1293.2007.00448.x

  6. You have free access to this content
    Treatment limitations imposed by antiretroviral drug resistance mutations: implication for choices of first line regimens in resource-limited settings

    HIV Medicine

    Volume 13, Issue 3, March 2012, Pages: 141–147, A Mtambo, K Chan, A Shen, V Lima, R Hogg, J Montaner and D Moore

    Version of Record online : 22 NOV 2011, DOI: 10.1111/j.1468-1293.2011.00950.x

  7. You have full text access to this OnlineOpen article
    Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues

    HIV Medicine

    Volume 14, Issue 9, October 2013, Pages: 571–577, MM Santoro, C Sabin, F Forbici, L Bansi, D Dunn, E Fearnhill, E Boumis, E Nicastri, A Antinori, G Palamara, A Callegaro, D Francisci, A Zoncada, F Maggiolo, M Zazzi, CF Perno, F Ceccherini-Silberstein and C Mussini

    Version of Record online : 13 MAY 2013, DOI: 10.1111/hiv.12044

  8. You have free access to this content
    Long-term beneficial effect of protease inhibitors on the intrinsic apoptosis of peripheral blood mononuclear cells in HIV-infected patients

    HIV Medicine

    Volume 13, Issue 8, September 2012, Pages: 469–478, N Jung, C Lehmann, M Knispel, EK Meuer, J Fischer, G Fätkenheuer, P Hartmann and D Taubert

    Version of Record online : 13 MAR 2012, DOI: 10.1111/j.1468-1293.2012.00999.x

  9. You have free access to this content
    Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors

    HIV Medicine

    Volume 8, Issue 8, November 2007, Pages: 529–535, P Chetchotisakd, S Anunnatsiri, P Mootsikapun, S Kiertiburanakul, T Anekthananon, C Bowonwatanuwong, B Kowadisaiburana, K Supparatpinyo, K Ruxrungtham and the study team

    Version of Record online : 18 OCT 2007, DOI: 10.1111/j.1468-1293.2007.00506.x

  10. You have free access to this content
    No increased risk of hepatotoxicity in long-term use of nonnucleoside reverse transcriptase inhibitors in HIV-infected patients

    HIV Medicine

    Volume 13, Issue 7, August 2012, Pages: 448–452, BJ Van Welzen, T Mudrikova, JE Arends and AIM Hoepelman

    Version of Record online : 13 MAR 2012, DOI: 10.1111/j.1468-1293.2012.00995.x

  11. You have free access to this content
    The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI

    HIV Medicine

    Volume 13, Issue 1, January 2012, Pages: 62–72, A Cozzi-Lepri, R Paredes, AN Phillips, B Clotet, J Kjær, V Von Wyl, G Kronborg, A Castagna, JR Bogner, JD Lundgren and for EuroSIDA in EuroCoord

    Version of Record online : 17 AUG 2011, DOI: 10.1111/j.1468-1293.2011.00943.x

  12. You have free access to this content
    Probing nonnucleoside inhibitor-induced active-site distortion in HIV-1 reverse transcriptase by transient kinetic analyses

    Protein Science

    Volume 16, Issue 8, August 2007, Pages: 1728–1737, Qing Xia, Jessica Radzio, Karen S. Anderson and Nicolas Sluis-Cremer

    Version of Record online : 2 JAN 2009, DOI: 10.1110/ps.072829007

  13. You have free access to this content
    Costs of adverse events among patients with HIV infection treated with nonnucleoside reverse transcriptase inhibitors

    HIV Medicine

    Volume 15, Issue 8, September 2014, Pages: 488–498, KN Simpson, S-Y Chen, AW Wu, L Boulanger, R Chambers, K Nedrow, M Tawadrous, CL Pashos and S Haider

    Version of Record online : 18 MAR 2014, DOI: 10.1111/hiv.12145

  14. You have free access to this content
    British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy

    HIV Medicine

    Volume 2, Issue 4, October 2001, Pages: 276–313, BHIVA Writing Committee on behalf of the BHIVA Executive Committee

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1464-2662.2001.00083.x

  15. You have free access to this content
    British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008

    HIV Medicine

    Volume 9, Issue 8, September 2008, Pages: 563–608, BG Gazzard and on behalf of the BHIVA Treatment Guidelines Writing Group

    Version of Record online : 15 SEP 2008, DOI: 10.1111/j.1468-1293.2008.00636.x

  16. Investigating the mutation resistance of nonnucleoside inhibitors of HIV-RT using multiple microsecond atomistic simulations

    Proteins: Structure, Function, and Bioinformatics

    Volume 82, Issue 1, January 2014, Pages: 130–144, Jacob I. Monroe, Walid G. El-Nahal and Michael R. Shirts

    Version of Record online : 17 SEP 2013, DOI: 10.1002/prot.24346

  17. You have free access to this content
    Successful switch to rilpivirine/tenofovir/emtricitabine in HIV-1-infected patients with an isolated K103N mutation acquired during prior nonnucleoside reverse transcriptase inhibitor therapy

    HIV Medicine

    Volume 15, Issue 10, November 2014, Pages: 611–614, C Rokx, A Verbon and BJA Rijnders

    Version of Record online : 16 APR 2014, DOI: 10.1111/hiv.12157

  18. You have full text access to this OnlineOpen article
    Nucleoside reverse transcriptase inhibitor-reducing strategies in HIV treatment: assessing the evidence

    HIV Medicine

    C Orkin, JM Llibre, S Gallien, A Antinori, GMN Behrens and A Carr

    Version of Record online : 24 JUL 2017, DOI: 10.1111/hiv.12534

  19. You have free access to this content
    Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins

    HIV Medicine

    Volume 6, Issue 5, September 2005, Pages: 326–333, D Rimland, JL Guest, I Hernández, C Del Rio, NA Le and WV Brown

    Version of Record online : 7 SEP 2005, DOI: 10.1111/j.1468-1293.2005.00316.x

  20. You have full text access to this OnlineOpen article
    Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals

    Intervention Review

    The Cochrane Library

    Lawrence Mbuagbaw, Sara Mursleen, James H Irlam, Alicen B Spaulding, George W Rutherford and Nandi Siegfried

    Published Online : 10 DEC 2016, DOI: 10.1002/14651858.CD004246.pub4